Shen, Yuqing <br/><br/>
GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI.  [electronic resource] 

 -  Anti-cancer drugs  Aug 2012 
 - 683-90 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0b013e3283549a22  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyloid Precursor Protein Secretases--antagonists & inhibitors<br/>Antineoplastic Agents--therapeutic use<br/>Basic Helix-Loop-Helix Transcription Factors--drug effects<br/>Benzodiazepinones--therapeutic use<br/>Calcium-Binding Proteins--drug effects<br/>Carbamates--therapeutic use<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival<br/>Dipeptides--therapeutic use<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genes, myc--drug effects<br/>Hep G2 Cells<br/>Homeodomain Proteins--drug effects<br/>Humans<br/>Intercellular Signaling Peptides and Proteins--genetics<br/>Jagged-1 Protein<br/>Liver Neoplasms--drug therapy<br/>Membrane Proteins--drug effects<br/>Oligopeptides--therapeutic use<br/>Receptors, Notch--antagonists & inhibitors<br/>Serrate-Jagged Proteins<br/>Transcription Factor HES-1